We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Licorice Lollipops May Reduce Tooth Decay

By HospiMedica International staff writers
Posted on 31 Aug 2011
A recent study suggests that sugar-free lollipops containing licorice root extract significantly reduce bacteria that cause tooth decay, specifically in high-risk preschool children.

Researchers at the University of Michigan (U-Mich; Ann Arbor, MI, USA) conducted a pilot study to determine the clinical effect of a simple herbal caries-prevention protocol aimed at reduction of Streptococcus mutans (SM) in young children in a preschool setting. More...
Supervised herbal lollipops were given twice daily for 3 weeks. Species-specific monoclonal antibody testing of saliva provided individual SM counts, and the children were grouped into high, medium, and low caries-risk using baseline SM-levels as risk indicator. Baseline, during intervention, and nine weeks post-intervention SM levels were then compared.

The results showed that high-risk children had the steepest early decrease in mean SM. At the end of the follow-up period, the decrease moved the high-risk group down to moderate-risk level, with the high-risk children showing a decrease in mean SM percentage not seen in other groups; the decrease reached a nadir 22-days post-intervention, when SM levels stabilized and then began to rebound. The results demonstrated that twice-daily use of herbal lollipop could significantly reduce both number and relative percent of SM in high-risk children. The study was published in the December 2010 issue of the European Academy of Pediatric Dentistry.

“This study is important not only for dental caries prevention research, but also demonstrates the feasibility of a classroom protocol using a unique delivery system suitable for young children,” said lead author Jacqueline Tallman, RDH, BSc, MPA, of the U-Mich school of dentistry. “Early prevention is key for lifetime oral health and effective innovative protocols are needed.”

“The use of the licorice root lollipops is an ideal approach as it will stop the transfer and implantation of the bacteria that cause dental decay from mothers to their infants and toddlers,” said Martin Curzon, editor-in-chief of the European Academy of Pediatric Dentistry. “It also has the merit of being a low cost-high impact public dental health measure.”

The lollipops are manufactured by Dr. John's Candies (Grand Rapids, MI, USA); the orange-flavored, sugarless lollipops contain extract of licorice root (Glycyrrhiza uralensis), which targets and is thought to kill primary SM, which is responsible for tooth decay.

Related Links:

University of Michigan
Dr. John's Candies



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.